In this fourth segment of an interview with Managed Healthcare Executive, Lyric CEO Rajeev Ronanki, M.S., discusses the use of artificial intelligence (AI) in finding errors in medical claims. "What we're doing is finding the billions of things that could go wrong in terms of human error or system error or a combination of the two," he said.
Lyric is finding inconsistencies between what's permissible and recommended by what's publicly available and in guidelines and then how the claim itself has been codified relative to those guidelines. "Imagine humans trying to ferret through all of that. It's going to be nearly impossible, right? So AI is essentially helping us find those patterns and detect those anomalies," Ronanki said. Humans are good at seeing a unique thing without much data because we instinctively know something is off, Ronanki said. Think of that as a sparse data problem. "What AI is really good at is looking at billions of data points in an instant and finding all the anomalies across everything that it has seen. Putting humans and AI together can "make a really powerful combination in our industry," Ronanki said.
Ronanki stressed that technology should play a supporting role in making clinical decisions. "When it comes to determining what's necessary and appropriate, that should be between a doctor and a patient," he said.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
July 25th 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
July 24th 2025The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Read More